跳至主要内容
临床试验/NCT02017691
NCT02017691已完成1 期

Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates During Immediate Transition After Birth (COSGOD) - a Prospective Two-centre Randomized Controlled Pilot Feasibility Study

Medical University of Graz3 个研究点 分布在 2 个国家目标入组 60 人开始时间: 2013年12月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
60
试验地点
3
主要终点
Cerebral tissue oxygen saturation (crSO2)

研究概览

简要总结

Objective: Objective of this pilot feasibility study is to monitor crSO2 using NIRS INVOS 5100 (Somanetics, USA) in addition to SpO2 monitoring to guide supplemental oxygen delivery and respiratory support based on both measurements in preterm neonates during the first 15 minutes after birth.

Patients: Preterm neonates <34+0 weeks of gestation born via caesarean section and/or who require respiratory support will be eligible for the study.

Design: A prospective two-centre randomized controlled pilot feasibility study

Methods: Study group: Pulse oximetry will be used to measure SpO2 and heart rate as routine non-invasive monitoring in the first minutes of resuscitation. In addition during the first 15 minutes NIRS measurements will be recorded. crSO2 measurements in addition SpO2 measurements will be used to guide supplemental oxygen support and respiratory support during the first 15 minutes after birth. Control group: Only SpO2 measurements will be used to guide supplemental oxygen support and respiratory support during the first 15 minutes after birth.

Hypothesis: Supplemental oxygen support and respiratory support guided by crSO2 and SpO2 measurements will reduce the time in % minutes of crSO2 <10th or >90th centile in preterm neonates during the first 15 minutes after birth

Outcome Parameter: Primary outcome parameter will be duration in % minute of crSO2 <10th or >90th centile.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 15 Minutes(Child)
性别
All
接受健康志愿者

入选标准

  • Preterm neonate <34+0 weeks after caesarean section
  • Decision to conduct full life support
  • Written informed consent

排除标准

  • No decision to conduct full life support
  • No written informed consent
  • Congenital malformation

研究组 & 干预措施

Near Infrared Spectroscopy

Experimental

crSO2 measurements in addition SpO2 measurements will be visible to guide supplemental oxygen support and respiratory support according predefined interventions depending on the infants breathing efforts and the heart rate during the first 15 minutes after birth

干预措施: Near Infrared Spectroscopy (Device)

Pulse-oximetry

Other

Only SpO2 measurements will be visible to guide supplemental oxygen support and respiratory support according predefined interventions depending on the infants breathing efforts and the heart rate during the first 15 minutes after birth

干预措施: Pulse-oximetry (Device)

结局指标

主要结局

Cerebral tissue oxygen saturation (crSO2)

时间窗: 15 minutes

Duration in % minute of crSO2 \<10th or \>90th centile

次要结局

  • Cerebral injury(16 weeks)
  • Mortality(16 weeks)
  • Neurodevelopmental outcome(16 weeks)

研究者

发起方
Medical University of Graz
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pichler Gerhard, MD.

Assoc. Prof.

Medical University of Graz

研究点 (3)

Loading locations...

相似试验

Cerebral Oxygenation to Guide Supplemental Oxygen | 临床试验